SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-042470
Filing Date
2013-08-01
Accepted
2013-08-01 16:12:44
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v350262_10q.htm 10-Q 483967
2 EXHIBIT 31.1 v350262_ex31-1.htm EX-31.1 9472
3 EXHIBIT 31.2 v350262_ex31-2.htm EX-31.2 10206
4 EXHIBIT 32.1 v350262_ex32-1.htm EX-32.1 4835
  Complete submission text file 0001144204-13-042470.txt   6968579

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acur-20130630.xml EX-101.INS 818027
6 XBRL TAXONOMY EXTENSION SCHEMA acur-20130630.xsd EX-101.SCH 48672
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20130630_cal.xml EX-101.CAL 35597
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20130630_def.xml EX-101.DEF 226170
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20130630_lab.xml EX-101.LAB 316624
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20130630_pre.xml EX-101.PRE 264528
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 131002865
SIC: 2834 Pharmaceutical Preparations